Mrs Azizah Attard

Specialist assessments offered

• Pharmaceutical negligence
• Fitness to Practice
• Pharmaceutical services
• Expert advice on psychopharmacological treatment options (for example in the case of detained patients who have been unable to progress as a result of their symptoms of mental disorder)
• Advice on the likelihood of a medication related side effect or adverse effect is associated with a change in behaviour, presentation and improvement or worsening of behaviour.
• If the treatment offered at the time of an offence or to date is in line with national guidance or evidence base.
• A drug history spanning the individuals care with services; this will include any possible side effects and clinical effectiveness or ineffectiveness of the treatment. Whether the treatment offered was at a therapeutic level and time line.

Publications

 In review at Therapeutic Advances in Psychopharmacology : Treating Psychiatric Conditions of patients with Co-morbid Postural Orthostatic Tachycardia Syndrome  (POTS). Attard A, Stanniland C, Rajappan K, Iles A, Attard S. Jan 2022

In review at Therapeutic Advances in Psychopharmacology Olanzapine Long Acting Injection, discontinuation rates and reasons for discontinuation: 10 years’ experience at a UK High Secure Hospital  Attard A*, Wakelam J, Broyd J, Taylor D, Hafferty J

Brugada Syndrome; should we be actively screening patients for this before prescribing a psychotropic medication? Attard A, Stanniland C, Rajappan K, Iles A, Attard S. Therapeutic Advances in Psychopharmacology: Oct 2021

My career as a mental health pharmacist during covid 19. Chopra P, Attard A and Parekh R. Pharmacy Management. May 2021

Clozapine: Why wait to start a laxative? Attard A, Iles A, Attard S, A Patel, N Atkinson. British Journal in Psychiatry Advances. May 2019

Paliperidone palmitate long-acting injection – prospective year-long follow-up of use  in clinical practice. Attard A, Olofinjana O, Cornelius V, Curtis V, Taylor D. Acta Psychiatr Scand. 2014 Jul;130(1):46-51. Epub 2013 Oct 1.

Mental state deterioration after switching from brand-name to generic olanzapine in an adolescent with bipolar affective disorder, autism and intellectual disability: a case study. Samuel R, Attard A, Kyriakopoulos M. BMC Psychiatry. 2013 Oct 4;13:244.

Antidepressants. Medicine 40(12); 681-183. December 2012, Azizah Attard

Comparative effectiveness of atypical antipsychotics in schizophrenia: what have real-world trials taught us? Attard A, Taylor DM. CNS Drugs. 2012 Jun 1;26(6):491-508.Review.

Acetylcholinesterase Inhibitors (AChEI’s) for the treatment of visual hallucinations in schizophrenia: a review of the literature. Patel SS, Attard A, Jacobsen P, Shergill S. BMC Psychiatry. 2010 Sep 7;10:69. Review.

Review: limited evidence that adding a second antipsychotic improves clozapine treatment in schizophrenia. Attard A, Gaughran F. Evid Based Ment Health. 2009 Nov;12(4):112

Alternative routes to oral antidepressant therapy: case vignette and literature review. Attard A, Ranjith G, Taylor D. J Psychopharmacol. 2010 Apr;24(4):449-54. Review.

Delirium and its treatment. Attard A, Ranjith G, Taylor D. CNS Drugs. 2008;22(8):631-44. Review.

A career as a psychiatric liaison pharmacist. Pharmaceutical Journal. 2008: 15(3). A Attard ; D McRobbie ; DM Taylor ; T West

Contributions to other publications

Service Improvement Guide: Self Administration of Medicines in Mental Health Hospitals

National Prescribing Centre 2008

Maudsley Prescribing Guidelines, South London and Maudsley and Oxleas NHS Trusts

Poster publications

Treating Psychiatric Conditions of patients with Co-morbid Postural Orthostatic Tachycardia Syndrome  (POTS). Attard A, Iles A, Attard S

British Association of Psychopharmacology 2021 Summer Meeting
Brugada Syndrome; should we be actively screening patients for this before prescribing a psychotropic medication?
Attard A, Iles A, Attard S

Clinical Pharmacy Congress 2021
The impact one pharmacist can have on Medicines Optimisation at Crisis Teams in 3 large London Boroughs
Nichofuric A and Attard A

Clinical Pharmacy Congress 2020
The impact a Prescribing Pharmacist had on a Community Mental Health Team
Stanniland C and Attard A

To measure the impact of digital temperature monitoring in clinical areas of a large London NHS Trust
Faculty of Clinical Informatics and Annual Scientific Conference 2020
Mouzaki S, Attard A and Monaharan G

International Congress 2015 Psychiatry, Birmingham 29 June-2 July 2015
Clozapine – does the GP know what the hospital is doing?
E Hardwood, A Attard, F Gaughran.

17^th Bienniel Winter Workshop on Schizophrenia, Marrakech, 14-16 February 2013
A naturalistic evaluation of the use of paliperidone palmitate at a South London NHS Foundation Trust: Factors that predict continuation with treatment in 216 patients
A Attard, DM Taylor

A naturalistic evaluation of the use of paliperidone palmitate at South London and Maudsley NHS Foundation Trust: Interim results on bed stay and admission rates on the first 132 patients diagnosed with Schizophrenia who were followed up for 12 months.
A Attard, DM Taylor

British Association of Psychopharmacology 2012 Summer Meeting
A naturalistic evaluation of the use of paliperidone palmitate at a South London TF07 NHS Foundation Trust: 6 month interim results on the first 120 patients
Attard, A., Taylor, DM.

Keynote speaker presentations

A naturalistic evaluation of the use of paliperidone palmitate (PP) at South London and Maudsley NHS Foundation Trust: The same old story? A Attard for Prof D M Taylor

Conference oral presentations

17^th Bienniel Winter Workshop on Schizophrenia, Marrakech, 14-16 February 2013
Expert Panel Member on Treatment Resistant Schizophrenia With the National Psychosis Unit

Schizophrenia Research In Science (SIRS), Florence 2012
“Cardiovascular side effects of antipsychotics”

National Psychosis Unit training days at locations across the United Kingdom for the Royal College of Psychiatrists
“Medication Options in Treatment Resistant Schizophrenia”